Medicare utilization — DR. KAUSHIK MOHANLAL HAZARIWALA (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 7,140 | 25 | $0 | $207,737 |
| J0178 | Injection, aflibercept, 1 mg | 2,344 | 223 | $0 | $1,623,617 |
| 92134 | Imaging of retina | 2,113 | 796 | $0 | $60,586 |
| 67028 | Injection of drug into eye | 1,321 | 283 | $0 | $121,479 |
| 92012 | Established patient problem focused exam of visual system | 1,188 | 452 | $0 | $73,983 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·